Gastrointestinal and Metabolism

Main Information

Description

The products in this category are provided with the aim of addressing the therapeutic needs related to liver health, stomach health, and the body's metabolic function. Relying on effective compounds and specialized pharmaceutical forms, they play an important role in the treatment path of patients.

Product Technical Description

In the field of gastrointestinal and metabolic medications, our products are designed with a focus on two important organs of the body, the liver and the stomach, to help manage digestive problems effectively. Relying on well-known formulations and clinical applications, these products are provided for use in therapeutic and hospital environments. Gastrointestinal medications include the following:

Liver Subgroup

  • Hepa Ornithate – Injectable concentrate containing L-Ornithine L-Aspartate
  • Helps support liver function and improve ammonia metabolism

Stomach Subgroup

  • Ulmezol – Lyophilized powder for injection containing omeprazole, used to prepare an intravenous injection solution.
  • Ulcezol – Powder for the preparation of an intravenous injection solution containing pantoprazole sodium, used to control stomach acid secretion and manage gastrointestinal problems.

This collection has been made available with the aim of providing reliable therapeutic solutions for supporting liver health and managing stomach disorders.

Similar Products

See all products
Kocak Farma logo

About the Business

Kocak Farma

Address:
  • Head Office: Turkey, Istanbul, Bagcilar, Kocak Farma Plaza, Mahmutbey Mah., 2477 Sokak, No:23, Postal Code: 34218
  • Kocak Farma Production Facilities: Turkey, Tekirdag, Kapakli, Organized Industrial Zone, Karaagac Mah., 11th Street No:5, Postal Code: 59520
  • Ayazaga Serum Manufacturing Facilities: Turkey, Istanbul, Sariyer, Ayazaga Mah., Kemerburgaz Street No:23

Kocak Farma: Over 50 Years of Activity in the Pharmaceutical Industry

Kocak Farma was established in 1971 and today is considered one of the well-known companies in the Turkish pharmaceutical industry in the field of producing human medicines and active pharmaceutical ingredients (APIs). Over more than five decades of activity, this company has transformed from a domestic manufacturer into an organization with a widespread presence in international markets, exporting its products to more than 40 countries worldwide.

Production and R&D Infrastructure

Kocak Farma's main production complex is located in the Çerkezkoy Organized Industrial Zone. With an area of approximately 140,000 square meters and over 100,000 square meters of indoor space, this facility is considered one of the largest pharmaceutical production centers in Turkey. Nearly 2,000 people work in the production, research and development, sales, and management departments of this complex.

The company's R&D center, which is approved by the Turkish Ministry of Science, Industry and Technology, focuses on the development of new products, improving formulations, and pharmaceutical production technologies. The activities of this center cover various therapeutic areas, the most important of which are:

  • Gynecology
  • Urology
  • Pulmonary Diseases
  • Cardiovascular Diseases
  • Oncology (Cancer)
  • General Health

Specialized Position in the Field of Oncology

Kocak Farma is considered one of the important active players in the field of anti-cancer drugs in Turkey. By holding more than 90 oncology product licenses and producing a portion of the raw materials for anti-cancer drugs domestically in Turkey, this company plays a significant role in the supply chain of this specialized field.

The company is also active in the development and production of advanced pharmaceutical products, including biosimilars, oncology products, softgel capsules, sterile preparations, vials, lyophilized ampoules, and pre-filled syringes, and has been one of the very first pharmaceutical companies in Turkey to produce some of these products.

Production Standards and Global Presence

Kocak Farma's production facilities are designed and approved according to EU GMP standards, enabling the production of a wide range of pharmaceutical dosage forms. In addition to the Turkish market, the company's products are exported to various countries, including Germany, France, Italy, Spain, South Korea, and Australia.

Besides manufacturing pharmaceuticals, Koçak Farma is actively involved in R&D, preparing drug registration dossiers, and contract manufacturing for international pharmaceutical companies. The company also holds ISO 9001, ISO 14001, and OHSAS 18001 certifications, reflecting its compliance with quality management, environmental, and occupational safety standards across all its processes.